DermIA: Machine Learning to Improve Skin Cancer Screening

This manuscript reviews DermIA , an online platform geared towards improving skin cancer surveillance. This mobile application allows users to capture images of suspicious lesions and have them evaluated using artificial intelligence technology on their mobile device. Users simply snap a picture of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of digital imaging 2021-12, Vol.34 (6), p.1430-1434
1. Verfasser: Shoen, Ezra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This manuscript reviews DermIA , an online platform geared towards improving skin cancer surveillance. This mobile application allows users to capture images of suspicious lesions and have them evaluated using artificial intelligence technology on their mobile device. Users simply snap a picture of their skin lesion, which then allows the DermIA technology to analyze the image. The system operates using neural network technology, which enables the program to adapt and analyze a user’s lesion. Per the application, the analysis can reach an accuracy of 95% on their free version and an accuracy of up to 98.2% on their premium version. As artificial intelligence and machine learning become a more integral part of our society, this mobile application has the potential to revolutionize skin cancer surveillance. Application Specs Application name: DermIA Analyze Skin Cancer with your camera AI Application developer: GeniaLabs Application developer website: N/A Application price: There is a free version of the application on the Google Play Store for Android devices. The application is $5.99 for the premium version. Category: Health and Fitness Installs: 10,000 +  Launch Date: May 2019 Tags: N/A Works offline: N/A FDA approval: N/A Quick Review (1 star, lowest; 5 stars, highest) Overall Rating (1–5): 5 Content (1–5): 4 Usability (1–5): 5
ISSN:0897-1889
1618-727X
DOI:10.1007/s10278-020-00395-1